Tag: TGA

As psychedelic medicine moves towards pharmaceutical development, Incannex is attempting to take synthetic psilocybin through the clinical, regulatory and commercial ...

Emyria (ASX: EMD) has cleared a key operational bottleneck across its Perth and Queensland psychedelic-assisted therapy operations, with therapist availability ...

As psychedelic-assisted therapy moves from research into clinical practice in Australia, the organisations building the infrastructure around the sector are ...

Emyria (ASX: EMD) has released its June 2026 quarterly update, highlighting strong revenue growth, national clinic expansion and encouraging early ...

Australia's medicines regulator has signalled it will reject a proposal to allow psilocybin-assisted therapy for end-of-life distress, raising fresh questions ...